Related Experiment Video
Updated: May 21, 2026
06:29
Workflow and Tools for Crystallographic Fragment Screening at the Helmholtz-Zentrum Berlin
Published on: March 3, 2021
Integrating fragmented software applications into holistic solutions: focus on drug discovery
1Ariadne Genomics, Inc., 9430 Key West Avenue, Suite 113, Rockville, MD 20850, USA +1 240 453 6296 ext 116 ; +1 270 912 6658 ; anton@ariadnegenomics.com.
Expert Opinion on Drug Discovery
|June 1, 2012
Summary
Holistic software solutions streamline drug discovery by integrating diverse data and enabling continuous analysis. These systems accelerate development, improve quality, and reduce costs, shifting focus towards computational approaches.
Area of Science:
- Computational drug discovery
- Bioinformatics software solutions
Background:
- Advances in software development and molecular profiling enable holistic solutions for drug discovery.
- Current solutions must integrate diverse data into a knowledge base for streamlined, continuous analysis workflows.
- Collaborative environments and broad experimental data import are crucial for holistic software.
Purpose of the Study:
- To review existing software applications and organizational challenges in drug development.
- To propose a conceptual framework for integrating software components in holistic solutions.
- To suggest implementation details for such integrated systems.
Main Methods:
- Review of disparate software applications in drug development.
- Discussion of organizational challenges for holistic software solutions.
- Proposal of a conceptual framework for software integration.
Main Results:
- Identification of current software limitations and integration challenges.
- A conceptual framework for holistic software solutions is proposed.
- Implementation strategies for integrated drug discovery software are suggested.
Conclusions:
- Holistic solutions significantly impact drug development speed, quality, and cost.
- Continuous evolution is necessary to adopt new methods and technologies.
- A shift towards computational approaches in pharmaceuticals is anticipated.
Related Concept Videos
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...
01:26Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:28Biopharmaceutics and Pharmacokinetics: Overview
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the appropriate...